Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review

PURPOSE: Intellectual disability (ID) is a chronic neurodevelopmental condition characterised by limitations in intelligence and adaptive skills with an onset prior to the age of 18 years. People with ID have complex healthcare needs and are more likely than the general population to experience mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Neasa, Kilmartin, Andrew, Lannon, Kevin, Lee, Caren, McLoughlin, Rory, Mulvanny, Lara, Mohamed, Omnyiah, Treacy, Mairead, Rossi, Karen, O’Connell, Juliette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546988/
https://www.ncbi.nlm.nih.gov/pubmed/36042024
http://dx.doi.org/10.1007/s00228-022-03375-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546988/
https://www.ncbi.nlm.nih.gov/pubmed/36042024
http://dx.doi.org/10.1007/s00228-022-03375-2

Ejemplares similares